Fig. 3

Maps showing high-risk human papillomavirus (HR-HPV) DNA testing rates among NJCEED participants during the study period (2009–2015), by county (a); HR-HPV infection among NJCEED participants who received at least one HR-HPV DNA test during the study period (2009–2015), by county (b); Age-adjusted cervical cancer incidence rates per 100,000 per year among all women in New Jersey (2010–2014), by county (c); and Age-adjusted cervical cancer mortality rates per 100,000 per year among all women in New Jersey (2010–2014), by county (d). NOTE: The rates of HR-HPV testing and infection are only among NJCEED participants (Fig. 3a and b), whereas the incidence and mortality rates of invasive cervical cancer are among all women in New Jersey (Fig. 3c and d). The maps depicted here are our own and were created using data from among the 50,510 NJCEED-enrolled women included in the analysis (Fig. 3a and b) and New Jersey State cervical cancer incidence and mortality data retrieved from www.statecancerprofiles.cancer.gov (Fig. 3c and d)